StocksMediumUpdated•Originally published 28 October 2026•Updated 29 October 2026•
1 min read
Teladoc Health Raises 2026 Guidance After Strong Q3 Results Beat
Key Facts
1Teladoc Health reported a GAAP EPS loss of $0.15, beating analyst estimates by $0.06.
2The company's revenue reached $605.1M, exceeding expectations by $15.01M.
Teladoc Health raised its full-year 2026 GAAP EPS guidance following its third-quarter financial results. The company reported a GAAP EPS loss of $0.15 for the quarter, beating analyst estimates by $0.06, while revenue reached $605.1 million according to Seeking Alpha.
TDOC closed at $6.45 on October 27, 2026, as the financial results showed stronger-than-anticipated performance and exceeded revenue expectations by $15.01 million. The stock traded between a high of $6.46 and a low of $6.18 during that session.